A detailed history of Capital Advisors Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Advisors Wealth Management, LLC holds 11,640 shares of ABBV stock, worth $2.14 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
11,640
Previous 11,392 2.18%
Holding current value
$2.14 Million
Previous $2.25 Million 8.05%
% of portfolio
0.37%
Previous 0.42%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$164.99 - $203.87 $40,917 - $50,559
248 Added 2.18%
11,640 $2.07 Million
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $17,367 - $21,128
106 Added 0.94%
11,392 $2.25 Million
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $153,242 - $178,952
990 Added 9.62%
11,286 $1.94 Million
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $587,977 - $669,945
-3,679 Reduced 26.33%
10,296 $1.87 Million
Q4 2023

Jan 08, 2024

BUY
$137.6 - $154.97 $86,000 - $96,856
625 Added 4.68%
13,975 $2.17 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $139,200 - $161,145
1,042 Added 8.47%
13,350 $1.99 Million
Q2 2023

Jul 11, 2023

BUY
$132.51 - $164.9 $68,110 - $84,758
514 Added 4.36%
12,308 $1.66 Million
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $108,168 - $124,571
748 Added 6.77%
11,794 $1.88 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $187,271 - $224,587
1,354 Added 13.97%
11,046 $1.79 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $670,378 - $768,880
4,995 Added 106.34%
9,692 $1.3 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $90,141 - $114,598
655 Added 16.2%
4,697 $719,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $76,152 - $94,483
577 Added 16.65%
4,042 $655,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $166,516 - $210,691
1,550 Added 80.94%
3,465 $469,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $203,756 - $231,293
1,915 New
1,915 $207,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Advisors Wealth Management, LLC Portfolio

Follow Capital Advisors Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Wealth Management, LLC with notifications on news.